Publications by Kevin Fishwick - ePrints

Browsing publications by Kevin Fishwick.

Newcastle Authors	Title	Year
Dr Ashraf Azzabi Dr Andrew Hughes Dr Paula Calvert Professor Ruth Plummer Melanie Griffin et al.	Phase I study of temozolomide plus paclitaxel in patients with advanced malignant melanoma and associated in vitro investigations	2005
Dr Mark Verrill Professor Alan Boddy Julieann Sludden Kevin Fishwick Lynsey Robson et al.	Phase 1 pharmacokinetic (PK) study of CT-2103 given Q2 or Q3 weeks in patients with solid tumors	2003
Professor Alan Boddy Dr Mark Verrill Julieann Sludden Kevin Fishwick Lynsey Robson et al.	Pharmacological study of CT-2103 (XyotaxTM), a poly(L-glutamic acid)-paclitaxel conjugate administered every 3 weeks or every 2 weeks in a phase I study	2002
Dr Andrew Hughes Dr Paula Calvert Dr Ashraf Azzabi Professor Ruth Plummer Melanie Griffin et al.	Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma	2002
Kevin Fishwick	The EORTC Clinical Research Coordinators Group	2002
Dr Andrew Simpson Dr Paula Calvert Julieann Sludden Professor Alan Boddy Melanie Griffin et al.	Topotecan in combination with carboplatin: phase I trial evaluation of two treatment schedules	2002
Dr Andrew Hughes Dr Ashraf Azzabi Professor Ruth Plummer Dr Jane Margetts Kevin Fishwick et al.	A phase I dose escalation study of doxorubicin in combination with pemetrexed (Alimta (R), multitargeted antifolate).	2001
Professor Alan Boddy Melanie Griffin Julieann Sludden Huw Thomas Kevin Fishwick et al.	Pharmacological study of paclitaxel duration of infusion combined with GFR-based carboplatin in the treatment of ovarian cancer	2001
Professor Alan Boddy Dr Mark Verrill Julieann Sludden Melanie Griffin Kevin Fishwick et al.	Phase I and pharmacological study of CT-2103, a poly(L-glutamic acid)-paclitaxel conjugate	2001
Professor Alan Boddy Melanie Griffin Julieann Sludden Huw Thomas Kevin Fishwick et al.	Paclitaxel and carboplatin dose-intensity and duration of infusion in the treatment of ovarian cancer	2000
Michael Batey Kevin Fishwick Dr Ashraf Azzabi Professor Herbie Newell Professor Alan Calvert et al.	Population pharmacokinetics of CMF in the adjuvant treatment of breast cancer	1999
Kevin Fishwick Lynsey Robson Professor Alan Calvert	Phase I study of pharmacologically based dosing of carboplatin with filgrastim support in women with epithelial ovarian cancer	1996